Skip to main content

Month: December 2020

Purpose Investments Inc. Announces 2020 Estimated Annual Capital Gains Distributions

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) today announced the estimated annual capital gains distributions for its open-end exchange-traded funds, mutual funds and closed-end funds (“Funds”) for the 2020 tax year end. The estimated distributions represent estimated capital gains realized by the Funds during the year.Details of the per unit distribution amounts are as follows:The estimated annual capital gain distribution for Purpose Gold Bullion Fund will be paid in cash. ETF unitholders of record on December 29, 2020 will receive the capital gain distributions on January 8, 2021. The ex-distribution date will be December 24, 2020.Purpose confirms that the following Funds are not expected to have annual capital gains distributions for the 2020 tax year:Open-End FundsPurpose Fund Corp. Funds:Purpose...

Continue reading

Captor Capital Releases Unaudited Financial Statements for the Quarter Ended September 30 2020

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), (“Captor” or the “Company”), is pleased to announce today the release of its Unaudited Quarterly Financial Statements and MD&A for the quarter ended September 30, 2020. For the six months from April 1 to September 30, 2020 revenues at the Company’s cannabis dispensaries were $7,676,067, with the Company recording a gross profit of $2,655,472 from the sale of cannabis. Revenues on cannabis sales were up approximately $1 million from the same period the year previous, while gross profit was up approximately $600,000.Financial Statement HighlightsDuring the six months ended September 30, 2020 the Company recorded revenues of $7,676,067 from the sale of cannabis at its retail dispensaries compared to $6,800,061 in the comparative...

Continue reading

Brachium Capital and WeCommerce File Filing Statement, Receive Conditional Approval and Provide Brachium Meeting Update

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Brachium Capital Corp. (“Brachium”) (TSXV: BRAC.P), a capital pool company, and WeCommerce Holdings Ltd. (“WeCommerce”) are pleased to announce that they have filed a filing statement dated November 30, 2020 (the “Filing Statement”) with the TSX Venture Exchange (the “Exchange”) for the previously announced proposed reverse take-over transaction, which is substantially described in Brachium’s press releases dated August 17, 2020, October 29, 2020 and November 26, 2020 (the “Qualifying Transaction”).Brachium and WeCommerce are also pleased to announce that the Exchange has provided conditional approval for the Qualifying Transaction and the concurrent private placement, proposed...

Continue reading

Reliq Health Technologies, Inc. Files Q1 FY2021 Financial Statements, Provides Corporate Update

HAMILTON, Ontario, Nov. 30, 2020 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare announced that the interim consolidated financial statements (“Financial Statements”) and Management’s Discussion and Analysis (“MD&A”) for the quarter ended September 30, 2020, are now available on the Company’s profile on SEDAR (www.sedar.com). The Company is also pleased to provide the following corporate update.As previously announced, Reliq will be hosting a webinar tomorrow, December 1st at 6:00am PST / 9:00am EST at https://bit.ly/37eU7rA. For those who are not able to attend the webinar, a recording of the webinar will be available on the Company’s...

Continue reading

Amarin Files Patent Infringement Lawsuit Against Hikma

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), announced today the filing of a patent infringement lawsuit by Amarin affiliates and a licensor against Hikma Pharmaceuticals PLC and Hikma’s U.S. affiliate. The lawsuit was filed in the United States District Court in Delaware. A copy of the complaint is available in the FAQ section of Amarin’s investor relations website.The Amarin complaint alleges that Hikma has induced the infringement of U.S. Patent Nos. 9,700,537 (Composition for preventing the occurrence of cardiovascular event in multiple risk patient), 8,642,077 (Stable pharmaceutical composition and methods of using same), and 10,568,861 (Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease) by making, selling,...

Continue reading

Tower One Announces Third Quarter 2020 Results and Provides an Update on the Progress of the Business

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announces that it has filed its financial results for the third quarter of 2020, and the related Management’s Discussion and Analysis, the details of which are available on the System for Electronic Document Analysis and Retrieval at www.sedar.com.“The last few quarters have shown the strength and resilience of the platform that the Company’s built in Latin America. While the construction was severely impacted during the first and second quarter of this year due to the strict lockdowns, our team continued to deliver value to our customers and the recurring tower lease business did not suffer the impact of the economic slowdown,” commented President and Chief Executive Officer...

Continue reading

UPDATE — Rackspace Technology Announces New Solve Strategy Series Webinar: How Businesses are using AI and Machine Learning Today

SAN ANTONIO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, will hold the virtual event How Businesses are using AI and Machine Learning Today on December 9th at 10:00 am CT as the final installment of the company’s Solve Strategy Series.Jeremy Howard, data scientist, researcher, educator and founder of fast.ai, will deliver a keynote on the top capabilities and constraints of artificial intelligence (AI) and machine learning (ML), including examples of successful applications and requirements to effectively put the technology into practice. He will then be joined by industry experts from Salesforce, AWS and Rackspace Technology for a panel discussion on how today’s enterprises are using AI/ML in new and innovative ways.For many enterprises, the...

Continue reading

Rackspace Technology Global Announces Early Tender Offer Results

SAN ANTONIO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT) (the “Company”) today announced the early tender results for its previously announced tender offer (the “Tender Offer”) to purchase for cash any and all of its outstanding 8.625% Senior Notes due 2024 (the “Notes”). The Tender Offer is subject to the terms and conditions set forth in the Offer to Purchase, dated November 16, 2020, relating thereto (the “Offer to Purchase”).As of the previously announced early tender deadline of 5:00 p.m., New York City time, on Monday, November 30, 2020 (the “Early Tender Time”), the Company has been advised by Global Bondholder Services Corporation, as Depositary for the Tender Offer, that $259,147,000 in aggregate principal amount, or approximately 49.91%, of the outstanding Notes had been validly tendered and not...

Continue reading

MedMira Reports FY2020 Fourth Quarter and Year End Financial Results

HALIFAX, Nova Scotia, Nov. 30, 2020 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2019.Profit and Loss HighlightsRevenue: The Company recorded revenues in FY2020 of $919,072 compared to $527,445 in FY2019. The increase in revenue was due to the Company’s additional revenues generated with the REVEALCOVID-19TM Total Antibody Test.Gross Profit: The Company recorded a gross profit in FY2020 of $572,280 compared to $423,351 for the same period last year.Operating expenses: In this financial year, the Company recorded operating expenses of $1,872,437 compared to $1,719,384 in FY2019. The increase of 9% in operating expenses were due to additional labour costs associated with the enhanced production for the Company’s REVEALCOVID-19TM Total Antibody...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.